BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

957 related articles for article (PubMed ID: 15106303)

  • 1. WHO hopes 3-by-5 plan will reverse Africa's HIV/AIDS epidemic.
    Fleck F
    Bull World Health Organ; 2004 Jan; 82(1):77-8. PubMed ID: 15106303
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA notifications. FDA gives tentative approval for stavudine, lamivudine & nevirapine tablet.
    AIDS Alert; 2009 Sep; 24(9):105-6. PubMed ID: 19938312
    [No Abstract]   [Full Text] [Related]  

  • 3. AIDS in Africa among women and infants: a human rights framework.
    Gostin LO
    Hastings Cent Rep; 2002; 32(5):9-10. PubMed ID: 12360777
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy and safety of generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-vir) in advanced HIV infection.
    Getahun A; Tansuphasawadikul S; Desakorn V; Dhitavat J; Pitisuttithum P
    J Med Assoc Thai; 2006 Sep; 89(9):1472-8. PubMed ID: 17100387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thailand markets low-cost, 3-in-1 antiretroviral medication.
    AIDS Policy Law; 2002 Apr; 17(8):8. PubMed ID: 12004875
    [No Abstract]   [Full Text] [Related]  

  • 6. [One world in hope?].
    Esmel D; Bi ET; Kouamé J; Kerouedan D
    Sante; 1997; 7(2):143-4. PubMed ID: 9273121
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy in Thai HIV-infected children aged two years or less.
    Puthanakit T; Aurpibul L; Sirisanthana T; Sirisanthana V
    Pediatr Infect Dis J; 2009 Mar; 28(3):246-8. PubMed ID: 19165130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.
    van Oosterhout JJ; Kumwenda JJ; Beadsworth M; Mateyu G; Longwe T; Burger DM; Zijlstra EE
    Antivir Ther; 2007; 12(4):515-21. PubMed ID: 17668560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort.
    Calmy A; Pinoges L; Szumilin E; Zachariah R; Ford N; Ferradini L;
    AIDS; 2006 May; 20(8):1163-9. PubMed ID: 16691068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thailand's do-it-yourself therapy.
    Cohen J
    Science; 2003 Sep; 301(5640):1662. PubMed ID: 14500957
    [No Abstract]   [Full Text] [Related]  

  • 11. [AIDS: the myth of Sisyphus].
    Jaubert D
    Med Trop (Mars); 1999; 59(1):31-2. PubMed ID: 10472577
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV/AIDS. Malawi: a suitable case for treatment.
    Cohen J
    Science; 2002 Aug; 297(5583):927-9. PubMed ID: 12169711
    [No Abstract]   [Full Text] [Related]  

  • 13. Performance of a World Health Organization first-line regimen (stavudine/lamivudine/nevirapine) in antiretroviral-naïve individuals in a Western setting.
    Tam LW; Hogg RS; Yip B; Montaner JS; Harrigan PR; Brumme CJ
    HIV Med; 2007 Jul; 8(5):267-70. PubMed ID: 17561871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To AIDS and back with Norvir, D4T, 3TC and nutritional therapies. An interview with Michael Golk.
    Golk M
    Posit Health News; 1998; (No 16):5-7. PubMed ID: 11365018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV/AIDS surges in Eastern Europe--Asia-Pacific next?
    Agnew B
    Bull World Health Organ; 2002; 80(1):78. PubMed ID: 11884980
    [No Abstract]   [Full Text] [Related]  

  • 16. Stavudine, lamivudine plus novel protease inhibitor therapy in antiretroviral-naive HIV-infected individuals treated for 24 weeks.
    Murphy RL
    Antivir Ther; 1999; 4 Suppl 3():85-7. PubMed ID: 16021877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The obstetric face and challenge of HIV/AIDS.
    Guidozzi F; Black V
    Clin Obstet Gynecol; 2009 Jun; 52(2):270-84. PubMed ID: 19407534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
    Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS treatment. A step toward cheaper anti-HIV therapy.
    Cohen J
    Science; 2005 Feb; 307(5710):653. PubMed ID: 15692020
    [No Abstract]   [Full Text] [Related]  

  • 20. HIV drug resistance after the use of generic fixed-dose combination stavudine/lamivudine/nevirapine as standard first-line regimen.
    Marcelin AG; Jarrousse B; Derache A; Ba M; Dakouo ML; Doumbia A; Haidara I; Maïga A; Carcelain G; Peytavin G; Katlama C; Calvez V
    AIDS; 2007 Nov; 21(17):2341-3. PubMed ID: 18090283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.